The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Functional Characterization of Three Mouse Formyl Peptide Receptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MIGEOTTE, I., COMMUNI, D., & PARMENTIER, M. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.009 · Cited by 457
Research works printed but not linked: 32
- Bürli, 2006, Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents, Bioorg Med Chem Lett, 16, 3713, 10.1016/j.bmcl.2006.04.068 · DOI
- Chen, 2010, A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses, J Immunol, 184, 3331, 10.4049/jimmunol.0903022 · DOI
- Chiang, 2006, The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo, Pharmacol Rev, 58, 463, 10.1124/pr.58.3.4 · DOI · Paper page
- Dufton, 2010, Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation, J Immunol, 184, 2611, 10.4049/jimmunol.0903526 · DOI · Paper page
- Forsman, 2011, What formyl peptide receptors, if any, are triggered by compound 43 and lipoxin A4?, Scand J Immunol, 74, 227, 10.1111/j.1365-3083.2011.02570.x · DOI
- Gao, 1998, Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse, Genomics, 51, 270, 10.1006/geno.1998.5376 · DOI
- Gao, 2007, F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor, J Immunol, 178, 1450, 10.4049/jimmunol.178.3.1450 · doi:10.4049/jimmunol.178.3.1450
- Gao, 1999, Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor, J Exp Med, 189, 657, 10.1084/jem.189.4.657 · DOI · Paper page
- Gao, 1993, Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains, J Biol Chem, 268, 25395, 10.1016/S0021-9258(19)74405-6 · DOI
- Hartt, 1999, N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR, J Exp Med, 190, 741, 10.1084/jem.190.5.741 · DOI
- He, 2003, Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R, Blood, 101, 1572, 10.1182/blood-2002-05-1431 · DOI · Paper page
- He, 2000, The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor, J Immunol, 165, 4598, 10.4049/jimmunol.165.8.4598 · DOI
- Lala, 1999, Human formyl peptide receptor function role of conserved and nonconserved charged residues, Eur J Biochem, 264, 495, 10.1046/j.1432-1327.1999.00647.x · DOI
- Le, 1999, Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation, J Immunol, 163, 6777, 10.4049/jimmunol.163.12.6777 · DOI · Paper page
- Le, 2002, Formyl-peptide receptors revisited, Trends Immunol, 23, 541, 10.1016/S1471-4906(02)02316-5 · DOI · Paper page
- Liberles, 2009, Formyl peptide receptors are candidate chemosensory receptors in the vomeronasal organ, Proc Natl Acad Sci USA, 106, 9842, 10.1073/pnas.0904464106 · DOI · Paper page
- Migeotte, 2005, Identification and characterization of an endogenous chemotactic ligand specific for FPRL2, J Exp Med, 201, 83, 10.1084/jem.20041277 · DOI
- Mills, 1998, Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry, J Biol Chem, 273, 10428, 10.1074/jbc.273.17.10428 · doi:10.1074/jbc.273.17.10428
- Mills, 2000, Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu, J Biol Chem, 275, 39012, 10.1074/jbc.M003081200 · DOI
- Nanamori, 2004, A novel nonpeptide ligand for formyl peptide receptor-like 1, Mol Pharmacol, 66, 1213, 10.1124/mol.104.004309 · DOI
- Quehenberger, 1997, Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach, Biochem Biophys Res Commun, 238, 377, 10.1006/bbrc.1997.7298 · DOI
- Rabiet, 2005, Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR, Eur J Immunol, 35, 2486, 10.1002/eji.200526338 · DOI · Paper page
- Rabiet, 2007, The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview, Biochimie, 89, 1089, 10.1016/j.biochi.2007.02.015 · DOI · Paper page
- Rabiet, 2011, N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation, J Biol Chem, 286, 26718, 10.1074/jbc.M111.244590 · doi:10.1074/jbc.m111.244590
- Rivière, 2009, Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors, Nature, 459, 574, 10.1038/nature08029 · DOI · Paper page
- Southgate, 2008, Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils, J Immunol, 181, 1429, 10.4049/jimmunol.181.2.1429 · DOI
- Takano, 1997, Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors, J Exp Med, 185, 1693, 10.1084/jem.185.9.1693 · DOI · Paper page
- Tiffany, 2011, Characterization of Fpr-rs8, an atypical member of the mouse formyl peptide receptor gene family, J Innate Immun, 3, 519, 10.1159/000327718 · doi:10.1159/000327718
- Vaughn, 2002, Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene, J Immunol, 169, 3363, 10.4049/jimmunol.169.6.3363 · DOI
- Vilven, 1998, Strategies for positioning fluorescent probes and crosslinkers on formyl peptide ligands, J Recept Signal Transduct Res, 18, 187, 10.3109/10799899809047744 · doi:10.3109/10799899809047744
- Ye, 2009, International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family, Pharmacol Rev, 61, 119, 10.1124/pr.109.001578 · DOI · Paper page
- Zhou, 2007, Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1, Mol Pharmacol, 72, 976, 10.1124/mol.107.037564 · doi:10.1124/mol.107.037564
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition
He, H.-Q., & Ye, R. (2017) · Molecules · doi:10.3390/molecules22030455 · Cited by 279
Self-citationDorward, D. A., Lucas, C. D., Chapman, G. B., Haslett, C., Dhaliwal, K., & Rossi, A. G. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.01.020 · Cited by 258
Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
Bäck, M., Powell, W. S., Dahlén, S., Drazen, J. M., Evans, J. F., Serhan, C. N., Shimizu, T., Yokomizo, T., & Rovati, G. E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12665 · Cited by 217
Metadata
- Authors
- He, H.-Q., Liao, D., Wang, Z.-G., Wang, Z.-L., Zhou, H.-C., Wang, M.-W., & Ye, R. D.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 83
- Issue
- 2
- Pages
- 389-398
- ISSN
- 0026-895X
- Cited by
- 65
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.